Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-07-30, with 96 holding rows worth $832,686,000.

Accession
0001415889-15-002492
Filed
2015-07-30
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, 96 entries on the cover page, a total value of $832,686,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $832,686,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287956ISHARES BIOTECH200,000$73,794,000thousands by filing dateput
SELECT SECTOR SPDR TR81369Y959PUT700,000$52,073,000thousands by filing dateput
UnitedHealth Group Inc91324P102COM231,000$28,182,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM132,800$24,006,000thousands by filing date
ALKERMES PLCG01767105SHS349,000$22,455,000thousands by filing date
BIOGEN INC COM09062X103Stock50,291$20,315,000thousands by filing date
CVS Health Corporation126650100COM184,000$19,298,000thousands by filing date
Johnson & Johnson478160104COM191,000$18,615,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM215,000$17,985,000thousands by filing date
CELGENE CORP151020104COM137,000$15,856,000thousands by filing date
AbbVie,Inc.00287Y109COM233,000$15,655,000thousands by filing date
Gilead Sciences,Inc.375558103COM130,000$15,220,000thousands by filing date
RITEAID CORP767754104COM1,817,000$15,172,000thousands by filing date
Merck & Co.,Inc.58933Y105COM260,000$14,802,000thousands by filing date
Eli Lilly and Company532457108COM175,000$14,611,000thousands by filing date
Bristol-Myers Squibb Company110122108COM198,000$13,175,000thousands by filing date
ALLERGAN PLCG0177J108SHS42,000$12,745,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM92,000$12,584,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock70,000$12,325,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM937,000$11,722,000thousands by filing date
Medtronic PlcG5960L103COM154,800$11,471,000thousands by filing date
INCYTE CORP COM45337C102Stock107,502$11,203,000thousands by filing date
Amgen Inc.031162100COM69,000$10,593,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock19,000$9,692,000thousands by filing date
CEMPRA INC15130J109COM277,161$9,523,000thousands by filing date
Elevance Health, Inc.036752103COM58,000$9,520,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock65,000$9,237,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock112,000$9,157,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock47,000$8,687,000thousands by filing date
BECTON DICKINSON & CO075887109COM60,000$8,499,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW70,000$8,485,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM191,000$7,999,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock61,400$7,360,000thousands by filing date
DEXCOM INC COM252131107Stock92,000$7,358,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW41,000$7,297,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM32,248$7,164,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM417,000$7,081,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM79,000$7,026,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK110,000$6,927,000thousands by filing date
ABIOMED INC003654100COM104,000$6,836,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM55,000$6,791,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK206,000$6,582,000thousands by filing date
AETNA INC NEW00817Y108COM51,000$6,500,000thousands by filing date
HCA Healthcare Inc40412C101COM69,000$6,260,000thousands by filing date
ST JUDE MED INC790849103COM83,000$6,065,000thousands by filing date
CYBERONICS23251P102COMMON STOCK100,000$5,946,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM24,000$5,793,000thousands by filing date
CERNER CORP156782104COM83,000$5,732,000thousands by filing date
MYLAN NVN59465109SHS EURO83,000$5,632,000thousands by filing date
MCKESSON CORP COM58155Q103Stock25,000$5,620,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM172,000$5,501,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR92,000$5,437,000thousands by filing date
ISIS PHARMACEUTICALS INC464330109COM94,000$5,410,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares619,600$5,341,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM60,765$5,340,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK534,000$5,329,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK28,000$5,321,000thousands by filing date
MEDIVATION INC58501N101COM46,000$5,253,000thousands by filing date
Lion Biotechnologies53619R102COM556,000$5,099,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK107,400$5,095,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM197,000$4,968,000thousands by filing date
THORATEC CORP885175307COM110,000$4,903,000thousands by filing date
AMSURG CORP03232P405COM70,000$4,897,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM37,000$4,801,000thousands by filing date
ENDO INTL PLCG30401106SHS58,976$4,697,000thousands by filing date
CENCORA INC COM03073E105Stock42,000$4,466,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock54,000$4,342,000thousands by filing date
XENCOR INC98401F105COMMON STOCK188,000$4,130,000thousands by filing date
MACROGENICS INC556099109COM107,959$4,099,000thousands by filing date
KITE PHARMA INC49803L109COM66,000$4,024,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock28,000$3,988,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK789,000$3,906,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock172,000$3,884,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM129,000$3,802,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM450,000$3,722,000thousands by filing date
HOLOGIC INC436440101COM93,000$3,540,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock76,000$3,462,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM265,427$3,241,000thousands by filing date
EPIZYME INC29428V104COM131,785$3,163,000thousands by filing date
CEPHEID15670R107COM51,000$3,119,000thousands by filing date
CHIMERIX INC COM16934W106Stock66,000$3,049,000thousands by filing date
TESARO INC881569107COM50,899$2,992,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK925,000$2,969,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW122,835$2,877,000thousands by filing date
OMNICELL COM COM68213N109Stock74,000$2,791,000thousands by filing date
INSULET CORP COM45784P101Stock90,000$2,789,000thousands by filing date
ENDOLOGIX INC29266S106COM179,000$2,746,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock370,000$2,668,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock154,006$2,501,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM280,000$2,481,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM209,000$2,266,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM50,000$1,574,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK170,915$1,376,000thousands by filing date
HEARTWARE INTL INC422368100COM15,700$1,141,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW201,537$814,000thousands by filing date
BIND THERAPEUTICS INC05548N107Cmn133,535$746,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-15-002492this filing2015-07-30acceptance time not in the bulk data set